Previous Presentations

May 2018
Presenter: Caroline Gentile, MS1
Resident Mentor: Hannah Levavi
Paper: KEYNOTE-024 Trial (Oncology)
Clinical Question: In patients with advanced non-small cell lung cancer (NSCLC) with PD-L1 expression, is pembrolizumab (anti PD-1 therapy) superior to platinum-based chemotherapy as first-line treatment?
Presentation: KEYNOTE Trial

April 2018

Presenter: Sukrit Narula, MS4
Resident Mentor: Andrew Bromley
Paper: COURAGE Trial (Cardiology)
Clinical Question: Is an initial management strategy of percutaneous coronary intervention (PCI) with intensive pharmacologic therapy and lifestyle intervention (optimal medical therapy) superior to optimal medical therapy alone in reducing the risk of cardiovascular events?
Presentation: COURAGE

January 2018

Presenter: John Power, MS4
Resident Mentor: Alexander Coltoff
Paper: CATCH Trial (Hematology/Oncology)
Clinical Question:  In patients with cancer, is Low-Molecular-Weight Heparin more effective and/or safer than Warfarin in preventing recurrent venous thromboembolism (VTE)?
Presentation: CATCH Trial

December 2017

Presenter: Katherine Phillips, MS1
Resident Mentor: Matthew Cagliostro
Paper: PARTNER-2 Trial (Interventional Cardiology)
Clinical Questions: In patients with symptomatic severe aortic stenosis who are intermediate-risk surgical candidates, is transcatheter aortic-valve implantation non-inferior to surgical aortic valve replacement with regard to all-cause mortality and disabling stroke?
Presentation: PARTNER2 Trial

November 2017:

Presenter: Peter Ting, MS4
Resident Mentor: Rajeev Samtani
Paper:  PEGASUS-TIMI-54 (Cardiology)
Clinical Question: Clinical Question: In patients who had an MI in the prior 1-3 years, does ticagrelor+ASA reduce the risk of cardiovascular death, myocardial infarction, or stroke as compared to placebo?
Presentation: PEGASUS-TIMI-54 Trial

May 2017:

Presenter: Ariel Pollock, MS4
Resident Mentor: Sheena Bhalla
Paper: ANITA trial (Heme-Onc)
Clinical Question: In patients with non-small cell lung cancer (NSCLC), does adjuvant chemotherapy with vinorelbine plus cisplatin improve survival?
Presentation: ANITA Trial
April 2017:
Presenter: Parth Kothari, MS4
Resident Mentor: Adam Winters
Paper: STOPAH Trial (GI)
Clinical Question: In patients with alcoholic hepatitis, is there a difference in mortality b/w treatment with prednisolone vs pentoxifylline?
Presentation: STOPAH Trial